TLR9 and cancer: Pancreatic ductal adenocarcinomas with high cytoplasmic TLR9 expression have a hazard ratio for cancer-specific death of 0.32 compared with TLR9-low cases (multivariate HR = 3.09 for low expression; p = 0.003) [51].